Prosecution Insights
Last updated: October 02, 2026

Examiner: EZEWOKO, MICHAEL I

Tech Center 3600 • Art Units: 1672 3626 3681 3682 3685

This examiner grants 62% of resolved cases

Analysis

Michael I Ezewoko is an examiner in Tech Center 3600 and Art Unit 1672, with 322 resolved cases. He maintains an allowance rate of 61.5 percent. This 61.5 percent rate is higher than the 51.2 percent interview lift. This figure serves as a benchmark for applications in this tech center. Practitioners should use the 61.5 percent baseline to assess their chances of success.

The interview lift is 51.2 percent. This indicates that conducting an interview offers a major increase in the chances of allowance compared to the 61.5 percent baseline. Practitioners should prioritize interviews to utilize this 51.2 percent lift when managing the 322 resolved cases. Direct communication is a key strategy for overcoming rejections in Art Unit 1672.

The median days to allowance is 1298. This timeline provides an expectation for the duration of successful prosecution. Given the 51.2 percent interview lift, direct communication may be an efficient way to navigate the 1298 day process. This 1298 day median is a reliable figure based on the 322 resolved cases.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

61.5%
Allow Rate
+9.5% vs TC avg
347
Total Applications
+51.2%
Interview Lift
1298
Avg Prosecution Days
Based on 322 resolved cases, 2023–2026

Rejection Statute Breakdown

36.5%
§101 Eligibility
7.1%
§102 Novelty
40.4%
§103 Obviousness
15.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19344087 SYSTEMS AND METHODS FOR ASSESSING SURGICAL ABILITY Non-Final OA Intuitive Surgical Operations, Inc.
18260965 BIOLOGICAL INFORMATION PROCESSING DEVICE, BIOLOGICAL INFORMATION PROCESSING SYSTEM, AND BIOLOGICAL INFORMATION PROCESSING METHOD Non-Final OA SONY GROUP CORPORATION
19328400 METHOD AND SYSTEM FOR RISK STRATIFICATION AND CHEMOTHERAPY RESISTANCE PREDICTION IN PANCREATIC DUCTAL ADENOCARCINOMA Non-Final OA OHIO STATE INNOVATION FOUNDATION
19362171 SYSTEMS AND METHODS FOR PROVIDING TEST RESULTS OF GENE SEQUENCING DATA ON A RECURRING BASIS Non-Final OA Helix, Inc.
18870565 DIGITAL MONITORING OF PATHOGEN LOAD IN LIVESTOCK Non-Final OA Evonik Operations GmbH
19137108 Systems And Devices For Collecting Health Data And Methods Of Using Same Non-Final OA Hill's Pet Nutrition, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month